Laekna, Inc. engages in the provision of clinical stage research and development of biopharmaceutical products. It primarily focuses on cancer and liver fibrosis. The company was founded by Xiang Yang Lu on July 29, 2016 and is headquartered in Shanghai, China.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
83
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Laekna Inc. market cap is $380.22M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Laekna Inc. 52 week high is $2.21 as of November 18, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Laekna Inc. 52 week low is $0.73 as of November 18, 2026.
Laekna Inc. stock price today is $0.9075.
Laekna Inc. stock price yesterday was $0.7593.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Laekna Inc.'s P/E ratio is -25.78.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Laekna Inc. P/B ratio is 2.1376.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Laekna Inc. 50-day moving average is $0.9075.